Bokf, Na Regeneron Pharmaceuticals, Inc. Transaction History

Bokf, Na

$5.65 Billion
Q3 2024

A detailed history of Bokf, Na transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Bokf, Na holds 1,745 shares of REGN stock, worth $1.24 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,745

Previous 1,965 11.2%

Holding current value

$1.24 Million

Previous $2.07 Million 11.19%

% of portfolio

0.03%

Previous 0.04%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1024.09 - $1201.76 $225,299 - $264,387	-220 Reduced 11.2%	1,745 $1.83 Million
Q2 2024 Aug 07, 2024	BUY	$883.2 - $1071.19 $105,984 - $128,542	120 Added 6.5%	1,965 $2.07 Million
Q1 2024 May 15, 2024	SELL	$902.69 - $993.35 $27,080 - $29,800	-30 Reduced 1.6%	1,845 $1.78 Million
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $10,077 - $11,462	13 Added 0.7%	1,875 $1.65 Million
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $1.4 Million - $1.7 Million	-2,015 Reduced 51.97%	1,862 $1.53 Million
Q2 2023 Aug 21, 2023	BUY	$700.03 - $830.35 $120,405 - $142,820	172 Added 4.64%	3,877 $2.79 Million
Q1 2023 May 11, 2023	SELL	$680.49 - $826.97 $567,528 - $689,692	-834 Reduced 18.37%	3,705 $3.04 Million
Q4 2022 Feb 13, 2023	BUY	$705.89 - $766.39 $349,415 - $379,363	495 Added 12.24%	4,539 $3.27 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $104,462 - $131,826	182 Added 4.71%	4,044 $2.79 Million
Q2 2022 Aug 11, 2022	SELL	$548.35 - $738.84 $2,193 - $2,955	-4 Reduced 0.1%	3,862 $2.28 Million
Q1 2022 May 13, 2022	BUY	$595.12 - $698.43 $85,102 - $99,875	143 Added 3.84%	3,866 $2.7 Million
Q4 2021 Mar 11, 2022	SELL	$543.48 - $670.97 $20,652 - $25,496	-38 Reduced 1.01%	3,723 $2.35 Million
Q3 2021 Nov 10, 2021	SELL	$574.03 - $680.96 $988,479 - $1.17 Million	-1,722 Reduced 31.41%	3,761 $2.28 Million
Q1 2021 Apr 21, 2021	SELL	$446.73 - $548.2 $337,281 - $413,891	-755 Reduced 12.1%	5,483 $2.59 Million
Q4 2020 Feb 12, 2021	BUY	$478.3 - $607.98 $281,718 - $358,100	589 Added 10.43%	6,238 $3.01 Million
Q3 2020 Oct 30, 2020	SELL	$544.75 - $658.21 $354,087 - $427,836	-650 Reduced 10.32%	5,649 $3.16 Million
Q2 2020 Aug 12, 2020	SELL	$493.32 - $643.92 $37,985 - $49,581	-77 Reduced 1.21%	6,299 $3.93 Million
Q1 2020 May 13, 2020	BUY	$336.18 - $494.43 $817,253 - $1.2 Million	2,431 Added 61.62%	6,376 $3.11 Million
Q4 2019 Feb 12, 2020	BUY	$274.13 - $376.51 $23,575 - $32,379	86 Added 2.23%	3,945 $1.48 Million
Q3 2019 Nov 13, 2019	SELL	$273.46 - $318.39 $365,889 - $426,005	-1,338 Reduced 25.75%	3,859 $1.07 Million
Q2 2019 Aug 14, 2019	SELL	$299.6 - $414.82 $8,089 - $11,200	-27 Reduced 0.52%	5,197 $1.63 Million
Q1 2019 May 15, 2019	BUY	$372.08 - $439.57 $40,184 - $47,473	108 Added 2.11%	5,224 $2.15 Million
Q4 2018 Feb 13, 2019	BUY	$335.82 - $403.04 $440,260 - $528,385	1,311 Added 34.45%	5,116 $1.91 Million
Q3 2018 Nov 13, 2018	BUY	$351.14 - $408.51 $121,845 - $141,752	347 Added 10.03%	3,805 $1.54 Million
Q2 2018 Aug 13, 2018	SELL	$284.6 - $344.99 $196,943 - $238,733	-692 Reduced 16.67%	3,458 $1.19 Million
Q1 2018 May 14, 2018	SELL	$315.82 - $393.78 $1.11 Million - $1.38 Million	-3,502 Reduced 45.77%	4,150 $1.43 Million
Q4 2017 Feb 14, 2018	BUY	$358.63 - $469.95 $78,181 - $102,449	218 Added 2.93%	7,652 $2.88 Million
Q3 2017 Nov 14, 2017	SELL	$431.38 - $504.0 $880,015 - $1.03 Million	-2,040 Reduced 21.53%	7,434 $3.32 Million
Q2 2017 Aug 14, 2017	BUY	N/A	9,474	9,474 $4.65 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bokf, Na, based on Form 13F filings with the SEC.

News

Stay updated on Bokf, Na with notifications on news.

Account